Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: MRR

USD 29.42 Bn growth in Manufacturing Execution Systems (MES) Market size | Shift toward Paperless Manufacturing Automation to Drive Growth | Technavio


NEW YORK, Oct. 27, 2021 /PRNewswire/ -- Technavio's latest offering, Manufacturing Execution Systems (MES) Market report provides a detailed analysis on the competitive scenario, the pre- and post-COVID-19 impact on businesses, and the market growth across various regions.

The manufacturing execution systems (MES) market value is anticipated to grow by USD 29.42 billion, progressing at a CAGR of almost 20% during the forecast period.

Market Dynamics

Factors such as continued demand for automation in industrial sectors and shift toward paperless manufacturing automation will drive the growth of the Manufacturing Execution Systems (MES) Market during 2021-2025. However, high upfront initial investment and complex installation procedures might hamper the market growth.

The compliance with stringent government regulations is expected to open multiple growth opportunities for players in the market. But the integration issues with control-based manufacturing execution systems (MES) might impact the business of vendors during the forecast period.

Company Profiles

The manufacturing execution systems (MES) market report includes information on the product launches, sustainability, and prospects of leading vendors including ABB Ltd., Dassault Systemes SE, Emerson Electric Co., General Electric Co., Honeywell International Inc., Oracle Corp., Rockwell Automation Inc., Schneider Electric SE, Siemens AG, and Yokogawa Electric Corp.

Competitive Analysis

The manufacturing execution systems (MES) market report includes the competitive analysis, which analyzes and evaluates the position of companies based on their industry position score and market performance score. Some of the factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Market Segmentation

Related Reports:

Global Tensiometer Market - Global tensioner market is segmented by end-user (chemical, oil and gas, energy, pharmaceutical and biopharmaceutical, and others) and geography (APAC, Europe, North America, South America, and MEA).
Download Exclusive Free Sample Report

Global Industrial Communication Market - Global industrial communication market is segmented by protocol (Fieldbus, industrial Ethernet, and wireless) and geography (APAC, North America, Europe, South America, and MEA).
Download Exclusive Free Sample Report

Manufacturing Execution Systems (MES) Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of almost 20%

Market growth 2021-2025

USD 29.42 billion

Market structure

Fragmented

YoY growth (%)

27.97

Regional analysis

APAC, North America, Europe, MEA, and South America

Performing market contribution

APAC at 34%

Key consumer countries

US, China, Germany, Japan, Canada, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

ABB Ltd., Dassault Systemes SE, Emerson Electric Co., General Electric Co., Honeywell International Inc., Oracle Corp., Rockwell Automation Inc., Schneider Electric SE, Siemens AG, and Yokogawa Electric Corp.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: